Using a $3.7M Sales for FY2018 (End Mar'18 Reports in mid July), 157M shares @ 23 cents per share I get a forward P/S of 9.76. Very Low compare to the Canadians Pot Stocks. Considering that GBLX is a biopharma and not just a retail company the valuation should be better. My 12 Months target is between 60 and 75 cents.. I'm going to keep adding to my position whenever possible..
Can anybody help me with the average retail price of a gram in the Las Vegas area.
News 
Market Data 
Discover 
